ARCHIVES

BMS, Exelixis To Collaborate On Drug Development.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014